1373862-45-3

Basic information

• Product Name: 2-chloro-5-fluoro-6-(2,2,2-trifluoroethoxy)nicotinic acid
• Synonyms: 2-chloro-5-fluoro-6-(2,2,2-trifluoroethoxy)nicotinic acid
• CAS NO: 1373862-45-3
• Molecular Weight: 273.571
• Mol File: 1373862-45-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-chloro-5-fluoro-6-(2,2,2-trifluoroethoxy)nicotinic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-5-fluoro-6-(2,2,2-trifluoroethoxy)nicotinic acid(1373862-45-3)
• EPA Substance Registry System: 2-chloro-5-fluoro-6-(2,2,2-trifluoroethoxy)nicotinic acid(1373862-45-3)

Safety Data

• Hazardous Substances Data: 1373862-45-3(Hazardous Substances Data)

Upstream product

• 75-89-8 2,2,2-trifluoroethanol 
• 82671-06-5 2,6-dichloro-5-fluoro-3-pyridinecarboxylic acid 

Relevant articles and documents

PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS

The present invention relates to pyrazolopyridine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS

The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.